Related Experiment Video
Updated: Jul 30, 2026

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
Published on: June 6, 2018
[Erectile dysfunction in those under 40. Etiological and contributing factors]
Javier Sánchez de la Vega1, Joaquín Amaya Gutiérrez, Jose Javier Alonso Flores
1Servicio de Urología, Hospital Universitario de Valme, Sevilla, España.
Objectives:
Although not very frequent, erectile dysfunction (ED) in patients younger than 40 years represents a disease to be kept in mind in our sanitary area. We propose a study of the various risk factors identified in this population group.
Methods:
We studied a total of 736 patients with diagnosis of ED following our protocol, using as inclusion criteria being between 19 and 40 years of age. In this group, we have studied the incidence of various risk factors associated with the disease both globally and dividing the group into age subgroups also.
Results:
Overall, we have diagnosed 64 patients with ED under the age of 40 years (8.7%). 25 of these patients were classified as psychogenic origin dysfunctions (39%), 26 organic (40.7%), and 13 of mixed origin (20.3%). Age subgroups analysis shows: between 19 and 25 years: 7 psychogenic, 2 mixed, and 5 organic; between 26 and 30: 1 psychogenic, 2 mixed, and 3 organic; between 31 and 35: 7 psychogenic, 3 mixed, and 8 organic; between 36 and 40: 11 psychogenic, 6 mixed, and 9 organic. We identified as risk factors, in order of prevalence: psychogenic (47%), diabetes (14.6%), cardiovascular (9.7%), toxic-alcohol, tobacco, and drugs--(12.1%), neurogenic (4.8%), and others (7.3%).
Conclusions:
ED under the age of 40 years causes a growing demand of medical care day by day, mainly due to the increasing prevalence of its etiologic factors. As other publications have shown psychogenic factors are the most frequently associated with the disease in younger patients globally, although when dividing by age groups we found different results than other publications in terms of association with various risk factors.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Infertility in Males
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Drug Toxicity: Risk factors
Coronary Artery Disease I: Introduction
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

